In an effort to bring some relief to Illinoisians dealing with health care cost burdens, lawmakers are targeting generic drug companies accused of price gouging.  HB 4900, the Illinois Generic Drug Pricing Fairness Act, would allow for the Illinois attorney general to be notified about price increases of essential off-patent or generic drugs under the Medical Assistance Program, Illinois Public Aid Code and the state health plan.